Document is current
Any future updates will be listed below
-
Authors
Lu, Ting
Ma, Rui
Dong, Wenjuan
Teng, Kun-Yu
Kollath, Daniel S.
Li, Zhiyao
Yi, Jinhee
Bustillos, Christian
Ma, Shoubao
Tian, Lei
Mansour, Anthony G.
Li, Zhenlong
Settles, Erik W. https://orcid.org/0000-0003-4331-3683
Zhang, Jianying
Keim, Paul S. https://orcid.org/0000-0003-0089-5820
Barker, Bridget M. https://orcid.org/0000-0002-3439-4517
Caligiuri, Michael A. https://orcid.org/0000-0002-4095-3020
Yu, Jianhua https://orcid.org/0000-0002-0326-3223
-
Funding
Funding for this research was provided by:
Flinn Foundation (2304)
Flinn Foundation (2304)
Arizona Board of Regents
Foundation for the National Institutes of Health (R35CA210087)
Foundation for the National Institutes of Health (R01CA068458)
Foundation for the National Institutes of Health (P01CA163205)
Foundation for the National Institutes of Health (R01NS106170)
Foundation for the National Institutes of Health (R01AI129582)
Foundation for the National Institutes of Health (R01CA247550)
Foundation for the National Institutes of Health (R21CA223400)
California Institute for Regenerative Medicine (DISC2COVID19-11947)
Leukemia and Lymphoma Society (1364-19)
- License Information
-
More Information
Article History
Received: 22 June 2021
Accepted: 20 April 2022
First Online: 11 May 2022
Competing interests
: Drs. Caligiuri and Yu are co-founders of CytoImmune Therapeutics, Inc. The remaining authors have no conflicts of interest to disclose.
